Cargando…
Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic
BACKGROUND: The 2019 novel coronavirus disease (COVID-19) pandemic has highlighted the importance of health research and fostered clinical research as never before. A huge number of clinical trials for potential COVID-19 interventions have been launched worldwide. Therefore, the effort of monitoring...
Autores principales: | Puopolo, Maria, Morciano, Cristina, Buoncervello, Maria, De Nuccio, Chiara, Potenza, Rosa Luisa, Toschi, Elena, Palmisano, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214678/ https://www.ncbi.nlm.nih.gov/pubmed/35733167 http://dx.doi.org/10.1186/s13063-022-06474-8 |
Ejemplares similares
-
The Janus Face of Tumor Microenvironment Targeted by Immunotherapy
por: Buoncervello, Maria, et al.
Publicado: (2019) -
Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020) -
COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021) -
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
por: Murphy, Michael, et al.
Publicado: (2020)